共 50 条
[1]
MENINI S, IACOBINI C, VITALE M, Et al., The inflamma-some in chronic complications of diabetes and related metabolic dis-orders[J], Cells, 9, 8, pp. 1-27, (2020)
[2]
UNAI G, ASIER B, SHIFA J, Et al., Pathophysiology of type 2 diabetes mellitus[J], International Journal of Molecular Sciences, 21, 17, (2020)
[3]
MIN X, LIU R, FU B, Et al., Correlation analysis combined with a floating reference measurement to improve the prediction ac-curacy of glucose in scattering media[J], Applied Spectroscopy, 71, 9, pp. 2076-2082, (2017)
[4]
YIN J X, LIN D R., Gut flora and disease[J], Bulletin of Biology, 53, 3, (2004)
[5]
LI Y G, XU W Y, ZHANG F, Et al., The gut microbiota-pro-duced indole-3-propionic acid confers the antihyperlipidemic effect of mulberry-derived 1-deoxynojirimycin[J], Msystems, 5, 5, pp. 1-15, (2020)
[6]
LARSEN N, VOGENSEN F K, VAN DEN BERG F W J, Et al., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults[J], PloS One, 5, 2, (2010)
[7]
WU H, ESTEVE E, TREMAROLI V, Et al., Metformin alters the gut microbiome of individuals with treatment-naive type 2 dia-betes, contributing to the therapeutic effects of the drug[J], Nature Medicine, 23, 7, pp. 850-858, (2017)
[8]
Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) (Part 1)[J], Chinese Journal of Practical Internal Medicine, 41, 8, (2021)
[9]
VIJAN S, SUSSMAN J B, YUDKIN J S, Et al., Effect of pa-tients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus[J], Jama Internal Medicine, 174, 8, (2014)
[10]
W ANG Q X, JIA M Y, TANG R P, Et al., The chemical constituents review of decreasing blood glucose in natural products[J], Chinese Journal of Ethnomedicine and Ethnopharmacy, 14, 4, pp. 190-193, (2005)